GLP-1 and adiponectin: Effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism

Obesity Surgery

Volumn 19, Issue 3, 2009, Pages 313-320

  De Carvalho, Camila Puzzi ^a   Marin, Daniela Miguel ^a   De Souza, Aglécio Luiz ^a   Pareja, José Carlos ^a   Chaim, Elintom Adami ^a   De Barros Mazon, Silvia ^a   Da Silva, Conceição Aparecida ^a   Geloneze, Bruno ^a   Muscelli, Elza ^a   Alegre, Sarah Monte ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Adiponectin; Gastric bypass surgery; GLP 1; Glucose metabolism disorders; Insulin resistance; Morbid obesity

Indexed keywords

ADIPONECTIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ARTICLE; CLINICAL ARTICLE; DIET RESTRICTION; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN METABOLISM; INSULIN SENSITIVITY; MALE; MORBID OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH BYPASS; TREATMENT OUTCOME; WEIGHT REDUCTION; ADULT; BLOOD; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; DISORDERS OF CARBOHYDRATE METABOLISM; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE METABOLISM DISORDERS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 65449152884     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-008-9678-5     Document Type: Article

References (55)

1. RC Bonadonna L Groop N Kraemer 1990 Obesity and insulin resistance in humans: a dose-response study Metabolism 39 452 459 (Pubitemid 20156310)
2. RA Defronzo RA Bonadonna E Ferranini 1990 A balanced overview Diabetes Care 15 318 368
3. GS Hostamisligil 2000 Molecular mechanisms of insulin resistance and the role of adipocyte Int J Obes 24 S23 S27
4. YW Park S Zhu L Palaniappan 2003 The metabolic syndrome: prevalence and associate risk factor finding in the US population from the Third National Health and Nutrition Examination Survey Arch Intern Med 163 427 436 (Pubitemid 36241019)
5. G Colditz W Willet A Rotniztky 1990 Weight as a risk factor for clinical diabetes in women Am J Epidemiol 132 501 513 (Pubitemid 20285148)
6. WJ Pories KG Macdonald Jr EJ Morgan 1992 Surgical treatment of obesity and its effect on diabetes: 10-y follow-up Am J Clin Nutr 55 582S 585S
7. L Residori P Garcia-Lorda L Flancbaum 2003 Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race Obes Surg 13 333 340 (Pubitemid 36718448)
8. H Buchwald Y Avidor E Brawnwald 2004 Bariatric surgery: a systemic review and meta-analysis JAMA 2992 1724 1737 (Pubitemid 39346675)
9. L Blandine H Stanley W Krystle 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 1709 1716 (Pubitemid 47036341)
10. PE MacDonald W El-kholy MJ Riedel 2002 The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion Diabetes 51 S434 S442 (Pubitemid 35403427)
11. W Creutzfedt 2001 The entero-insulinar axis in type 2 diabetes. Incretins as therapeutic agents Exp Clin Endocrinol Diabetes 109 S288 S303
12. JM Egan GS Meneilly JF Haberner 2002 Glucagon-like peptide augments insulin-mediated glucose uptake in obese state J Clin Endocrinol Metab 87 3768 3773
13. I Valverde ML Villanueva-Penacarrillo WJ Malaisse 2002 Pancreatic and extrapancreatic effects of GLP-1 Diabetes Metab 28 3S85 3S89 (Pubitemid 36077143)
14. ML Villanueva-Penacarrillo J Puente A Redondo 2001 Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in NDDM and IDDM rats Endocrine 15 241 248 (Pubitemid 32977337)
15. A Acitores N Gonzáles V Sancho 2005 Participation of protein kinases in the stimulant action of GLP-1 upon 2-deoxy-D-glucose uptake by normal rat skeletal muscle Horm Metab Res 37 275 280 (Pubitemid 40896209)
16. V Sancho MV Trigo N González 2005 Effects of GLP-1 and exendins on kinase activity, 2-deoxy-D-glucose transport, lipolysis and lipogenesis in adipocytes from normal and streptozotocin-induced type 2 diabetic rats J Mol Endocrinol 35 27 38 (Pubitemid 41167623)
17. C Ruiz-Grande C Alarcón E Mérida 1992 Lipolytic action of glucagon-like peptides in isolated rat adipocytes Peptides 13 13 16
18. A Perea C Vinambres F Clement 1997 GLP-1 (7-36) amide effects on glucose transport and metabolism in rat adipose tissue Horm Metab Res 9 417 421 (Pubitemid 27454107)
19. ML Villanueva-Penacarrillo L Márquez N González 2001 Effect of GLP-1 on lipid metabolism in human adipocytes Horm Metab Res 33 73 77 (Pubitemid 32231985)
20. A Nauck MM Heinesaat C Orskov 1993 Preserved incretin activity of synthetic human gastric inhibitory polypeptide in patients with type 2 diabetes J Clin Invest 91 301 307
21. L Blandine H Stanley W Krystle 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 1709 1716 (Pubitemid 47036341)
22. K Maeda K Okubo J Simomura 1996 c-DNA cloning and expression of a novel adipose-specific collagen-like factor, ap M1 (adipose most abundant gene transcript 1) Biochem Biophys Res Commun 221 286 289 (Pubitemid 26136463)
23. PE Scherer S Williams M Fogliano 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 26746 26749
24. E Hu P Liang BM Spiegelman 1996 AdipoQ is a novel adipose-specific gene dysregulated in obesity J Biol Chem 18 10697 10730 (Pubitemid 26145805)
25. M Takahashi Y Arita K Yamagata 2000 Genomic structure and mutations in adipose-specific gene, adiponectin Int J Obes 24 861 868 (Pubitemid 30449921)
26. Y Okamoto M Arita Y Nishida 2000 An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls Horm Metab Res 32 47 50 (Pubitemid 30143606)
27. N Ouchi S Kihara T Arita 1999 Novel modulator of endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 2473 2476 (Pubitemid 30005109)
28. N Ouchi S Kihara T Arita 2000 Adiponectin, and adipocyte-derived plasma protein, inhibits NF-kb signaling through a cAMP-dependent pathway Circulation 102 1296 1301 (Pubitemid 30143606)
29. T Yokota K Oritani I Takahashi 2000 Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages Blood 96 1723 1732 (Pubitemid 30661055)
30. C Weyer T Funahashi S Tanaka 2001 Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 1930 1935 (Pubitemid 32472900)
31. WS Yang WJ Lee T Funahashi 2001 Weight reduction increases plasma levels of an adipose-derived anti-inflammatory, adiponectin J Clin Endocrinol Metab 86 3815 3819 (Pubitemid 32755982)
32. K Hotta T Funahashi Y Arita 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 1595 1599 (Pubitemid 30353893)
33. N Stefan B Vozarova T Funahashi 2002 Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitvity in humans Diabetes 51 1884 1888 (Pubitemid 34564302)
34. National Institutes of Health. The Seventh Report of Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). NIH Publication no. 03-5233. EUA, 2003; p. 2-3.
35. MAL Fobi H Lee D Igwe 2001 Revision on failed gastric bypass to distal Roux-en-Y gastric bypass: a review of 65 cases Obes Surg 11 190 195 (Pubitemid 33701860)
36. GR Fulcher M Farrer M Walker 1991 A comparison of measurements of lean body mass derived by bioelectrical impedance, skinfold thickness and total body potassium. A study in obese and non-obese normal subjects Scand J Lab Invest 51 245 253
37. American Diabetes Association 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Clinical practice recommendations 2003: committee report. The expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 1 S4 S20
38. JA Potteiger DJ Jacobsen JE Donnelly 2002 A comparison of methods for analyzing glucose and insulin areas under the curve following nine months of exercise in overweight adults Int J Obes 26 87 89 (Pubitemid 34098674)
39. KA Mcauley SM Williams JI Mann 2001 Diagnosing insulin resistance in the general population Diabetes Care 24 460 464 (Pubitemid 32198413)
40. DR Matthews JP Hosker AS Rudenski 1985 Homeostasis model assessment, insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 (Pubitemid 15018832)
41. CD Sjostrom M Peltonem H Wedel 2000 Differentiated long-term effects of intentional weight loss on diabetes and hypertension Hypertension 36 20 25 (Pubitemid 30602147)
42. Marin, D. Resistência à insulina e função da célula beta: Efeito da perda de peso após bypass gástrico. PhD Thesis, Universidade Estadual de Campinas. Faculdade de Ciências Médicas; 2007.
43. Y Matsuzawa T Funahashi T Nakamura 1999 Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive Substances Ann NY Acad Sci 892 146 154 (Pubitemid 129500522)
44. E Tomas TS Tsao AK Saha 2002 Enhanced muscle fat oxidation and glucose transport by ACRP 30 globular domain: a domain: acetyl- CoaA carboxylase inhibition and AMP- activated protein kinase activation Proc Natl Acad Sci USA 99 16309 16313 (Pubitemid 35462791)
45. T Yamauchi J Kamon Y Minokashi 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat Med 8 1288 1295 (Pubitemid 35373562)
46. T Yokota K Oritani I Takahashi 2000 Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and function of the macrofages Blood 96 1723 1732 (Pubitemid 30661055)
47. C Weyer T Funahashi S Tanaka 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 1930 1935 (Pubitemid 32472900)
48. J Fruebis TS Tsao S Javorschi 2001 Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc Natl Acad Sci USA 98 2005 2010 (Pubitemid 32165613)
49. JJ Host 2004 On the physiology of GIP and GLP-1 Horm Metab Res 34 747 754 (Pubitemid 40115894)
50. T Vilsboll JJ Host 2004 Incretins, insulin secretion and type 2 diabetes mellitus Diabetologia 47 357 366 (Pubitemid 38491230)
51. SE Greenway F Greenway S Klein 2002 Effects of obesity surgery on non-insulin-dependent diabetes mellitus Arch Surg 137 1109 1177 (Pubitemid 35155242)
52. DJ Drucker 2003 Glucagon-like peptide-1 and the islet ß-cell: augmentation of cell proliferation and inhibition of apoptosis Endocrinology 144 5145 5148 (Pubitemid 37476039)
53. M Zander S Masdbad JL Madsen 2002 Effect of 6-week course of glucagon-like peptide 1 on glycemic control, insulin sensitivity, and ß-cell function in type 2 diabetes: a parallel-group study Lancet 359 824 830 (Pubitemid 34233752)
54. DJ Drucker 2003 Enhancing incretin action for treatment of type 2 diabetes Diabetes Care 26 2929 2940 (Pubitemid 37205571)
55. DA Cummings J Overduin K Fosyrt-Schubert 2004 Gastric bypass for obesity: mechanism of weight loss and diabetes resolution J Clin Encrinol Metab 89 2608 2615 (Pubitemid 38766339)